How Do Regulatory Bodies Address Impurity Thresholds for Compounded Peptides versus Approved Drugs?
Regulatory bodies mandate rigorous, molecule-specific impurity qualification for approved drugs, while applying harmonized quality and process standards for compounded peptides.
HRTioAugust 1, 2025